CLINICAL_TRIALS
trial_result
· 2017-06-08
Clinical Trial Update: Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma [Phase 2]
Summary
Phase 2 trial evaluating dupilumab in patients with persistent moderate-to-severe eosinophilic asthma reports on efficacy, safety, and tolerability outcomes. Th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08